title: Pre-immunization with an intramuscular injection of AAV9-human erythropoietin vectors reduces the vector-mediated transduction following re-administration in rat brain.
abstract: We have recently demonstrated that adeno-associated virus serotype 9 (AAV9)-mediated human erythropoietin (hEPO) gene delivery into the brain protects dopaminergic (DA) neurons in the substantia nigra in a rat model of Parkinson's disease. In the present study, we examined whether pre-exposure to AAV9-hEPO vectors with an intramuscular or intrastriatal injection would reduce AAV9-mediated hEPO transduction in rat brain. We first characterized transgene expression and immune responses against AAV9-hEPO vectors in rat striatum at 4 days, 3 weeks and 6 months, and with doses ranging from 10(11) to 10(13) viral genomes. To sensitize immune system, rats received an injection of AAV9-hEPO into either the muscle or the left striatum, and then sequentially an injection of AAV9-hEPO into the right striatum 3 weeks later. We observed that transgene expression exhibited in a time course and dose dependent manner, and inflammatory and immune responses displayed in a time course manner. Intramuscular, but not intrastriatal injections of AAV9-hEPO resulted in reduced levels of hEPO transduction and increased levels of the major histocompatibility complex (MHC) class I and class II antigen expression in the striatum following AAV9-hEPO re-administration. There were infiltration of the cluster of differentiation 4 (CD4)-and CD8-lymphacytes, and accumulation of activated microglial cells and astrocytes in the virally injected striatum. In addition, the sera from the rats with intramuscular injections of AAV9-hEPO contained greater levels of antibodies against both AAV9 capsid protein and hEPO protein than the other treatment groups. hEPO gene expression was negatively correlated with the levels of circulating antibodies against AAV9 capsid protein. Intramuscular and intrastriatal re-administration of AAV9-hEPO led to increased numbers of red blood cells in peripheral blood. Our results suggest that pre-immunization with an intramuscular injection can lead to the reduction of transgene expression in the striatal re-administration.
authors.affiliation: Department of Anatomy, Capital Medical University, Beijing, China.
authors.forename: Chun
authors.initials: C
authors.lastname: Yang
authors.forename: Wei-Hua
authors.initials: WH
authors.lastname: Yang
authors.forename: Sha-Sha
authors.initials: SS
authors.lastname: Chen
authors.forename: Bao-Feng
authors.initials: BF
authors.lastname: Ma
authors.forename: Bin
authors.initials: B
authors.lastname: Li
authors.forename: Tao
authors.initials: T
authors.lastname: Lu
authors.forename: Ting-Yu
authors.initials: TY
authors.lastname: Qu
authors.forename: Ronald L
authors.initials: RL
authors.lastname: Klein
authors.forename: Li-Ru
authors.initials: LR
authors.lastname: Zhao
authors.forename: Wei-Ming
authors.initials: WM
authors.lastname: Duan
mesh_terms: D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism*; D000229:Dependovirus / Q000235:genetics; D004921:Erythropoietin / Q000008:administration & dosage / Q000235:genetics / Q000378:metabolism*; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007114:Immunization / Q000379:methods*; D007273:Injections, Intramuscular; D008285:Major Histocompatibility Complex / Q000235:genetics; D009500:Neutralization Tests; D051381:Rats; D014161:Transduction, Genetic / Q000379:methods*; D019076:Transgenes / Q000235:genetics
chemical_list: D004921:Erythropoietin